(Q37379547)

20 August 2017

1 reference

title

Review paper: the role of inflammation in mouse pulmonary neoplasia (English)

1 reference

20 August 2017

0 references

A K Bauer

1

1 reference

PubMed ID

19176494

20 August 2017

E A Rondini

series ordinal

2

1 reference

20 August 2017

27 January 2009

1 reference

20 August 2017

1 reference

20 August 2017

46

1 reference

20 August 2017

3

1 reference

20 August 2017

369-390

1 reference

The CXC chemokine, monokine induced by interferon-gamma, inhibits non-small cell lung carcinoma tumor growth and metastasis

20 August 2017

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Blocking oncogenic Ras signaling for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Signalling pathways of the TNF superfamily: a double-edged sword

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Prevention of mouse lung tumors and modulation of DNA methylation by combined treatment with budesonide and R115777 (ZarnestraMT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Prevention of mouse lung tumors and modulation of DNA methylation by combined treatment with budesonide and R115777 (Zarnestra MT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Expression of both TNF-alpha receptor subtypes is essential for optimal skin tumour development

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Lung cancer risk among female textile workers exposed to endotoxin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Computed tomography screening and lung cancer outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Smoldering and polarized inflammation in the initiation and promotion of malignant disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Inflammation and cancer: back to Virchow?

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Rising incidence of bronchioloalveolar lung carcinoma and its unique clinicopathologic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Toll-like receptor 4 in butylated hydroxytoluene-induced mouse pulmonary inflammation and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

The lung tumor promoter, butylated hydroxytoluene (BHT), causes chronic inflammation in promotion-sensitive BALB/cByJ mice but not in promotion-resistant CXB4 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Butylated hydroxytoluene (BHT) induction of pulmonary inflammation: a role in tumor promotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Susceptibility to neoplastic and non-neoplastic pulmonary diseases in mice: genetic similarities

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Immunobiology of toll-like receptors in allergic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Control of transcription by steroid hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

The mechanisms of action of PPARs

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Tnfa and Il‐10 deficiencies have contrasting effects on lung tumor susceptibility: Gender‐dependent modulation of IL‐10 haploinsufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Cellular responses to interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Antitumoral activity of interferon-gamma involved in impaired immune function in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Antitumorigenic effects of peroxisome proliferator-activated receptor-gamma in non-small-cell lung cancer cells are mediated by suppression of cyclooxygenase-2 via inhibition of nuclear factor-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Inhibition of lung tumorigenesis by NSAIDS: a working hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Genetic variants in peroxisome proliferator-activated receptor-gamma gene are associated with risk of lung cancer in a Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Linkage analysis of susceptibility to hyperoxia. Nrf2 is a candidate gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Innate immune control of pulmonary dendritic cell trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

21 January 2018

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Mechanisms of glucocorticoid involvement in mouse lung tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Cytokines differentially regulate the synthesis of prostanoid and nitric oxide mediators in tumorigenic versus non-tumorigenic mouse lung epithelial cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Evidence for in situ expansion of diverse antitumor-specific cytotoxic T lymphocyte clones in a human large cell carcinoma of the lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Effects of subchronically inhaled carbon black in three species. I. Retention kinetics, lung inflammation, and histopathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Inflammation in the development of lung cancer: epidemiological evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Systematic evaluation of genetic variants in the inflammation pathway and risk of lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

The molecular cell biology of interferon-gamma and its receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

TLR4 signaling is essential for survival in acute lung injury induced by virulent Pseudomonas aeruginosa secreting type III secretory toxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

At least four loci and gender are associated with susceptibility to the chemical induction of lung adenomas in A/J x BALB/c mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Prostaglandin E2 regulates angiogenesis via activation of fibroblast growth factor receptor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

The contributions of cyclooxygenase-2 to tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Activated neutrophils inhibit nucleotide excision repair in human pulmonary epithelial cells: role of myeloperoxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Chemoprevention of vinyl carbamate-induced lung tumors in strain A mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Bleomycin hydrolase and a genetic locus within the MHC affect risk for pulmonary fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Prostaglandin synthase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Toll-like receptor 4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistance to Bordetella pertussis by inhibiting inflammatory pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Nitric oxide in cancer and chemoprevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

TLR4 signaling attenuates ongoing allergic inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Cooperativity of glucocorticoid response elements located far upstream of the tyrosine aminotransferase gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

21 January 2018

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

K-ras activation generates an inflammatory response in lung tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Increased risk of cancer among relatives of patients with lung cancer in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

EP2, a receptor for PGE2, regulates tumor angiogenesis through direct effects on endothelial cell motility and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

NF-kappaB in cancer: from innocent bystander to major culprit

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Pulmonary prostacyclin synthase overexpression chemoprevents tobacco smoke lung carcinogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Identification of bronchioalveolar stem cells in normal lung and lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Celecoxib reduces pulmonary inflammation but not lung tumorigenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Impaired preneoplastic changes and liver tumor formation in tumor necrosis factor receptor type 1 knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Occupational exposure to eight organic dusts and respiratory cancer among Finns

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Will sewage workers with endotoxin related symptoms have the benefit of reduced lung cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Polymorphisms in immunoregulatory genes, smoky coal exposure and lung cancer risk in Xuan Wei, China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

PGE2 inhibits apoptosis in human adenocarcinoma Caco-2 cell line through Ras-PI3K association and cAMP-dependent kinase A activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Distinct role of macrophages in different tumor microenvironments

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Additional evidence that the K-ras protooncogene is a candidate for the major mouse pulmonary adenoma susceptibility (Pas-1) gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Chlamydia pneumoniae and lung cancer: epidemiologic evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Increased level of exhaled nitric oxide and up-regulation of inducible nitric oxide synthase in patients with primary lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Use of p53 transgenic mice in the development of cancer models for multiple purposes

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Genetic studies on lung tumor susceptibility and histogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Role of inflammation in mouse lung tumorigenesis: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Quantitative trait locus mapping of susceptibilities to butylated hydroxytoluene-induced lung tumor promotion and pulmonary inflammation in CXB mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

The chemokine system in diverse forms of macrophage activation and polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

COX inhibitors and thromboregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Epidemiologic evidence of cancer risk in textile industry workers: a review and update

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

The lymphotoxin pathway: beyond lymph node development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Decreased lung tumorigenesis in mice genetically deficient in cytosolic phospholipase A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Effects of cyclo-oxygenase inhibition on exhaled eicosanoids in patients with COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Lipoxygenase inhibitors prevent lung carcinogenesis and inhibit non-small cell lung cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Role of the negative glucocorticoid regulatory element in glucocorticoid repression of the human osteocalcin promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Effects of novel 5-lipoxygenase inhibitors on the incidence of pulmonary adenomas in the A/J murine model when administered via nose-only inhalation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Inducible nitric oxide synthase: what difference does it make?

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Molecular mechanisms of glucocorticoid action: what is important?

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

NS-398 inhibits tumor growth and liver metastasis of colon cancer through induction of apoptosis and suppression of the plasminogen activation system in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Strategies for use of IL-10 or its antagonists in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Glucocorticoid hormone effect on transplacental carcinogenesis and lung differentiation: influence of histocompatibility-2 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Inhaled corticosteroids and risk of lung cancer among patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Cancer burden in the year 2000. The global picture

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Effects of sulindac and oltipraz on the tumorigenicity of 4-(methylnitrosamino)1-(3-pyridyl)-1-butanone in A/J mouse lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Prevention of mouse lung tumors by budesonide and its modulation of biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

The mouse as a model for human biology: a resource guide for complex trait analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

NF-kappaB functions as a tumour promoter in inflammation-associated cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Lung cancer survival and functional polymorphisms in MBL2, an innate-immunity gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Meta- and pooled analysis of GSTT1 and lung cancer: a HuGE-GSEC review

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Prostaglandin E2-EP4 receptor promotes endothelial cell migration via ERK activation and angiogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Tumor signaling to the bone marrow changes the phenotype of monocytes and pulmonary macrophages during urethane-induced primary lung tumorigenesis in A/J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Cytokine gene polymorphisms in idiopathic pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Down-regulation of cytokine-induced cyclo-oxygenase-2 transcript isoforms by dexamethasone: evidence for post-transcriptional regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Glutathione transferase pi plays a critical role in the development of lung carcinogenesis following exposure to tobacco-related carcinogens and urethane.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

The ras oncogenes in human lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Hormone-mediated repression: a negative glucocorticoid response element from the bovine prolactin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

A meta-analysis of asthma and risk of lung cancer (United States).

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Chronic inflammation: a common and important factor in the pathogenesis of neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Alterations in NF-kappaB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Joint effect of asthma/atopy and an IL-6 gene polymorphism on lung cancer risk among lifetime non-smoking Chinese women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

SLC/CCL21-mediated anti-tumor responses require IFNgamma, MIG/CXCL9 and IP-10/CXCL10

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

The involvement of genetic polymorphism of IL-10 promoter in non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Cyclooxygenases: structural, cellular, and molecular biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Mechanisms of glucocorticoid receptor signaling during inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Epithelial NF-kappaB activation promotes urethane-induced lung carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Cyclooxygenase-2-dependent and -independent inhibition of proliferation of colon cancer cells by 5-aminosalicylic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Myeloperoxidase G-463A polymorphism and lung cancer: a HuGE genetic susceptibility to environmental carcinogens pooled analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Lung cancer death rates in lifelong nonsmokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Complexity of lung cancer modifiers: mapping of thirty genes and twenty-five interactions in half of the mouse genome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

The role of lymphotoxin receptor signaling in diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Increasing complexity of the Ras signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Regulatory T cells and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

A chemically induced model for squamous cell carcinoma of the lung in mice: histopathology and strain susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Initial sequencing and comparative analysis of the mouse genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Chemoprevention of pulmonary carcinogenesis by brief exposures to aerosolized budesonide or beclomethasone dipropionate and by the combination of aerosolized budesonide and dietary myo-inositol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

The chemokine receptor D6 has opposing effects on allergic inflammation and airway reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Increased risk of fibrosing alveolitis associated with interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

The chemopreventive effects of orally administered dexamethasone in Strain A/J mice following cessation of smoke exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Chemoprevention of tobacco smoke-induced lung tumors in A/J strain mice with dietary myo-inositol and dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Budesonide exerts its chemopreventive efficacy during mouse lung tumorigenesis by modulating gene expressions

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Protective role of Toll-like receptor 4 during the initiation stage of cutaneous chemical carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Cutting edge: TLR4 deficiency confers susceptibility to lethal oxidant lung injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Polymorphisms of the interleukin-1 beta gene are associated with increased risk of non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Regulatory T cells, tumour immunity and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Lung Cancer Risk: Effect of Dairy Farming and the Consequence of Removing that Occupational Exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Repression of Cyclooxygenase-2 and Prostaglandin E2Release by Dexamethasone Occurs by Transcriptional and Post-transcriptional Mechanisms Involving Loss of Polyadenylated mRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

Macrophage expression of interleukin-10 is a prognostic factor in nonsmall cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1354%2FVP.08-VP-0217-B-REV

10.1354/VP.08-VP-0217-B-REV

21 January 2018

Identifiers

DOI

1 reference

20 August 2017

1 reference

PubMed ID

19176494